People with blood type A may be more vulnerable to coronavirus, China study finds

People with blood type A may be more vulnerable to infection by

the new coronavirus, while those with type O seem more resistant, according to a preliminary study of patients in China who contracted the disease known as Covid-19.
- Advertisement -

Medical researchers in China took blood group patterns of more than 2,000 patients infected with the virus in Wuhan and Shenzhen and compared them to local healthy populations. They found that blood type A patients showed a higher rate of infection and they tended to develop more severe symptoms.

While the researchers said the study was preliminary and more work was needed, they did urge governments and medical facilities to consider blood type differences when planning mitigation measures or treating patients with the virus, known as Sars-CoV-2.

“People of blood group A might need particularly strengthened personal protection to reduce the chance of infection,” wrote the researchers led by Wang Xinghuan with the Centre for Evidence-Based and Translational Medicine at Zhongnan Hospital of Wuhan University.

“Sars-CoV-2-infected patients with blood group A mig

In contrast, “blood group O had a significantly lower risk for the infectious disease compared with non-O blood groups”, according to a paper they published on on March 11.

Of 206 patients who had died from Covid-19 in Wuhan, 85 had type A blood, which was 63 per cent more than the 52 with type O. The pattern existed across different age and gender groups.

“It might be helpful to introduce ABO blood typing in both patients and medical personnel as a routine part of the management of Sars-CoV-2 and other coronavirus infections, to help define the management options and assess risk exposure levels of people,” Wang wrote in the paper.

The study was conducted by scientists and doctors from cities across China including Beijing, Wuhan, Shanghai and Shenzhen. It has not been peer reviewed, and the authors cautioned that there could be risks involved in using the study to guide current clinical practice.

Gao Yingdai, a researcher with the State Key Laboratory of Experimental Haematology in Tianjin who was not involved in the study, said it could be improved with a larger sample size. Though 2,000 was not small, it is dwarfed by the total number of patients infected by the coronavirus

Now exceeding 180,000 globally


Another limitation of the study was that it did not provide a clear explanation about the phenomenon, such as the molecular interaction between the virus and different types of red blood cells, Gao said.

- Advertisement -